ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,681.20
      -2.17%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.245
      0.16%
      Bitcoin
      57,173.38
      -0.31%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Auris Medical Holding AG (EARS)

      7. Auris Medical Holding AG (EARS) News

      EARS

      Auris Medical (EARS)

      Auris Medical Holding AG
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:EARS
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      12/07/20204:10PMGlobeNewswire Inc.Auris Medical Holding to Present at the 13th Annual LD Micro Main Event ConferenceNASDAQ:EARSAuris Medical Holding AG
      12/07/20203:50PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:EARSAuris Medical Holding AG
      12/03/20205:26PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
      12/03/20205:25PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:EARSAuris Medical Holding AG
      12/02/20208:45AMGlobeNewswire Inc.Auris Medical Holding Ltd. Prices $8,000,000 Common Shares Offering Priced At-the-MarketNASDAQ:EARSAuris Medical Holding AG
      12/02/20207:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
      12/01/20209:00AMGlobeNewswire Inc.Auris Medical Reports Positive In vitro Efficacy Data for AM-301 in Protecting Against Sars-CoV-2 InfectionNASDAQ:EARSAuris Medical Holding AG
      11/20/20209:10AMGlobeNewswire Inc.Auris Medical Launches Website for AM-301-focused Subsidiary, Altamira MedicaNASDAQ:EARSAuris Medical Holding AG
      11/16/20205:08PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EARSAuris Medical Holding AG
      11/16/20205:03PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EARSAuris Medical Holding AG
      11/02/20206:05AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EARSAuris Medical Holding AG
      10/13/20209:00AMGlobeNewswire Inc.Auris Medical Announces Initiation of Part B of TRAVERS Phase 2 Study with AM-125 in VertigoNASDAQ:EARSAuris Medical Holding AG
      10/09/20204:31PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
      10/06/20204:19PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:EARSAuris Medical Holding AG
      09/17/202011:49AMEdgar (US Regulatory)Amended Report of Foreign Issuer (6-k/a)NASDAQ:EARSAuris Medical Holding AG
      09/17/20208:00AMGlobeNewswire Inc.Auris Medical Provides Business Update and Reports First Half 2020 Financial ResultsNASDAQ:EARSAuris Medical Holding AG
      09/11/20208:00AMGlobeNewswire Inc.Auris Medical to Report First Half 2020 Financial Results and Provide Business Update on Thursday, September 17, 2020NASDAQ:EARSAuris Medical Holding AG
      09/08/20208:36AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:EARSAuris Medical Holding AG
      09/08/20208:30AMGlobeNewswire Inc.Auris Medical Launches Development of Drug-Free Nasal Spray for Protection against Airborne Pathogens and AllergensNASDAQ:EARSAuris Medical Holding AG
      09/03/20208:30AMGlobeNewswire Inc.Auris Medical Announces Positive Interim Data from TRAVERS Phase 2 Study with AM-125 in VertigoNASDAQ:EARSAuris Medical Holding AG
      08/20/20204:30PMGlobeNewswire Inc.Auris Medical Regains Listing Compliance with NASDAQ Minimum Bid RequirementNASDAQ:EARSAuris Medical Holding AG
      08/20/20204:08PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:EARSAuris Medical Holding AG
      07/29/20208:30AMGlobeNewswire Inc.Auris Medical Announces Completion of Enrollment into First Part of TRAVERS Phase 2 Study with AM-125 in VertigoNASDAQ:EARSAuris Medical Holding AG
      07/02/20204:36PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:EARSAuris Medical Holding AG
      06/24/20206:02AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EARSAuris Medical Holding AG
      06/24/20206:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EARSAuris Medical Holding AG
      06/05/20204:32PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:EARSAuris Medical Holding AG
      05/26/20208:30AMGlobeNewswire Inc.Auris Medical Announces Positive Top-Line Data from AM-201 Phase 1b Study in Antipsychotic-Induced Weight Gain and Provides U...NASDAQ:EARSAuris Medical Holding AG
      05/26/20206:04AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:EARSAuris Medical Holding AG
       Showing the most relevant articles for your search:NASDAQ:EARS